Hodgkin's disease is divulging its secrets at last. Despite the fact that Hodgkin's disease was the first lymphoma to be recognized as a distinct clinical entity ([1][1]), it has proved to be one of the most difficult lymphomas to approach molecularly. The clonal, malignant Hodgkin/Reed-Sternberg (H
No takes yet. Share an insight, caveat, or question.
Louis M. Staudt (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: